搜索筛选:
搜索耗时2.1379秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Tong Wu,Xuan Wu,Hong-Yang Wang,
来源：癌症 年份：2019
肿瘤免疫微环境与肿瘤的发生、预后和免疫治疗反应密切相关。不同类型肿瘤的免疫图谱、浸润免疫细胞数量和肿瘤中淋巴细胞的定位各不相同。癌症的免疫环境是由肿瘤浸润淋巴细...
Resected lung adenocarcinoma with micropapillary pattern displays higher positive rates of ALK expre
[会议论文] 作者：Cuicui Zhang,Shaomei Li,Zhen He,Xuan Wu,Qiming Wang,
来源：2019中国肿瘤学大会 年份：2019
...
Next-generation sequencing identified a novel WDPCP-ALK fusion sensitive to crizotinib in lung adeno
[会议论文] 作者：Xuan Wu,Zhen He,Zhe Zhang,Hongyong Fu,Qiming Wang,
来源：2019中国肿瘤学大会 年份：2019
Objective Lung cancer is the leading cause of cancer-related deaths worldwide.Over 85%of lung cancers are classified as non-small cell lung cancer(NSCLC)....
Benefits of etoposide maintenance therapy for patients with extensive SCLC who responded to first-li
[会议论文] 作者：Cuicui Zhang,Zhen He,Shaomei Li,Xuan Wu,Qiming Wang,
来源：2019中国肿瘤学大会 年份：2019
Objective The current study aims to evaluate the efficacy and safety of etoposide capsules of different doses as maintenance therapy in extensive SCLC patients responded to first line EP/EC treatment....
Sequential therapy of radiotherapy and anlotinib identified significant efficacy and safety in a pat
[会议论文] 作者：Xuan Wu,Zhen He,Shuxiang Ma,Zhe Zhang,Cuicui Zhang,Shuai Wang,Sheng Yu,Qiming Wang,
来源：2019中国肿瘤学大会 年份：2019
Objective In recent years,patients with lung adenocarcinoma have benefited significantly from tyrosine kinase inhibitors(TKIs),but not for lung squamous cell carcinoma....
相关搜索：
